FDA Quietly Changes End Date For Study Of Heart Inflammation After Pfizer COVID Vaccination | ZeroHedge
ZeroHedge - On a long enough timeline, the survival rate for everyone drops to zero
So the original study ordered by the FDA "Pfizer was supposed to complete a study on the occurrence of subclinical myocarditis, or heart inflammation, after receipt of its COVID-19 vaccine. The completion date was listed by the FDA in 2021 as June 20, 2022. Pfizer was also supposed to submit the results of the study to the FDA by the end of 2022 as part of a list of requirements the FDA imposed as a condition of approving Pfizer’s jab. " Has been postponed for a year. Without a reason given.